Related Experiment Video
Updated: Jul 31, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?
Yoshihiko Horimoto1, Ikuko Aiba, Takeshi Yasuda
1Second Department of Internal Medicine, Medical School, Nagoya City University, Mizuho, Japan.
Abstract:
Several investigators have revealed features of multiple system atrophy (MSA) by magnetic resonance imaging (MRI). For use in clinical diagnosis, we determined the exact time when two main features of pontine and putaminal intensity changes appeared. Furthermore, in order to reveal the course from when the disorder first appeared and how it spread, we also investigated the course of MRI findings and differences between clinical subtypes. The cranial MRI of 42 patients with MSA were longitudinally studied including comments on the so called "cross sign" of pontine T2 high intensity, which was divided into 6 stages, and also on the linear T2 high intensity of the dorsolateral side of the putamen ("putaminal slit") which was divided into 4 stages. Patients were classified as 16 MSA-C, 7 autonomic dominant type (MSA-A), and 19 MSA-P. The age at onset ranged from 41 to 74 years (mean, 55 +/- 9). The duration of the disease in the MRI study ranged from 1 to 24 years. The pontine "cross sign" was completed (shows Cross, stage IV) earlier in MSA-C mainly before 5 years, later in MSA-P and even much later in MSA-A. Regarding the "putaminal slit", MSA-P shows earlier bilateral changes (stage II), mostly before 3 years, compared with MSA-C, which requires 4 years to reveal even a unilateral change (stage I), or MSA-A which requires even more time. MRI findings showed a tendency to relate to clinical findings, since MSA-C exhibits "cross sign" completion earlier than bilateral "putaminal slit"; however, MSA-P shows bilateral "putaminal slit" earlier than "cross sign", and MSA-A requires much more time to show both. Clinically, MSA-C, MSA-A, or MSA-P showed different MRI courses so that three subtypes could be defined also with MRI findings. Therefore these observations are useful not only for diagnosis of MSA itself, but also to distinguish clinical subtypes (MSA-C, MSA-A, or MSA-P) which have different rates of lesion progression.
Insights
Magnetic resonance imaging (MRI) reveals distinct timelines for pontine "cross sign" and putaminal "slit" in multiple system atrophy (MSA) subtypes. These MRI findings aid in diagnosing MSA and differentiating subtypes based on lesion progression rates.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Multiple System Atrophy (MSA) diagnosis relies on identifying characteristic MRI features.
- Understanding the temporal evolution of these MRI findings is crucial for accurate diagnosis and subtyping.
Purpose of the Study:
- To determine the exact timing of key MRI features (pontine "cross sign" and putaminal "slit") in MSA.
- To investigate the progression of MRI findings and their correlation with clinical subtypes (MSA-C, MSA-A, MSA-P).
Main Methods:
- Longitudinal cranial MRI analysis of 42 patients with MSA.
- Staging of pontine "cross sign" (6 stages) and putaminal "slit" (4 stages).
- Classification of patients into MSA-C, MSA-A, and MSA-P subtypes.
Main Results:
- Pontine "cross sign" completion occurred earlier in MSA-C (before 5 years), later in MSA-P, and much later in MSA-A.
- "Putaminal slit" showed earlier bilateral changes in MSA-P (before 3 years) compared to MSA-C (4 years for unilateral) and MSA-A.
- MRI findings correlated with clinical subtypes: MSA-C showed earlier "cross sign" than "putaminal slit"; MSA-P showed earlier bilateral "putaminal slit" than "cross sign".
Conclusions:
- MRI findings exhibit distinct temporal patterns that correlate with MSA clinical subtypes.
- These observations support the use of MRI for diagnosing MSA and differentiating between MSA-C, MSA-A, and MSA-P based on lesion progression.
Related Concept Videos
Multiple Sclerosis l: Introduction
Alterations in Muscle Tone lll

